JimTechAIM
@jimtechaim.bsky.social
Private investor favouring AIM recovery / growth UK Small Caps.
#AOTI #EKF #GENI #IXI #KOO #OMG #RUA #STX
Thought I'd dodged a bullet when I sold Aquis in June for 17% profit and the share price tumbled.
I sold because I was unsure that market volumes would recover and I have market exposure through my holding of Jarvis Securities #JIM.L.
Today #AQX.L recommended offer at 727p.
Congratulations holders!
I sold because I was unsure that market volumes would recover and I have market exposure through my holding of Jarvis Securities #JIM.L.
Today #AQX.L recommended offer at 727p.
Congratulations holders!
November 11, 2024 at 10:20 AM
Bought back into Oxford BioDynamics in April and have added further.
The #OBD.L June HY presentation illustrated an impressive product pipeline with the CEO "very bullish" that a non-dilutive partnering deal would be forthcoming by the end of the year.
Sales slow but novel IP attractive.
Speculative
The #OBD.L June HY presentation illustrated an impressive product pipeline with the CEO "very bullish" that a non-dilutive partnering deal would be forthcoming by the end of the year.
Sales slow but novel IP attractive.
Speculative
October 10, 2024 at 6:35 AM
Bought back into Oxford BioDynamics in April and have added further.
The #OBD.L June HY presentation illustrated an impressive product pipeline with the CEO "very bullish" that a non-dilutive partnering deal would be forthcoming by the end of the year.
Sales slow but novel IP attractive.
Speculative
The #OBD.L June HY presentation illustrated an impressive product pipeline with the CEO "very bullish" that a non-dilutive partnering deal would be forthcoming by the end of the year.
Sales slow but novel IP attractive.
Speculative